Telehealth for motor neurone disease
Authors: Robert D Henderson, Nicole Hutchinson, James A Douglas and Carol Douglas
Published online: 7 July 2014
To the Editor: Telehealth is an expanding area with emerging evidence of use in the management of motor neurone disease (MND) and home mechanical ventilation.1-3 Here, we report our experience with the use of telehealth for managing MND in Queensland.
MND is a devastating disease with affected patients having an average life expectancy of 2–3 years. Progressive muscle weakness leads to the loss of speech and ability to swallow, inability to use arms and legs and, eventually, respiratory failure. Patients are usually reviewed in specialised outpatient clinics at major Australian tertiary hospitals.4 However, as the disease advances, MND patients find it difficult to attend these clinics because of advanced disability.
As in other centres in Australia, in Brisbane, the Royal Brisbane and Women's Hospital (RBWH) and, separately, The Prince Charles Hospital (TPCH) have multidisciplinary MND clinics that involve medical, nursing and allied health staff. Since 2008, a monthly MND telehealth clinic has been conducted (using a dedicated bandwidth, average 768 kbps) for patients across Queensland and northern New South Wales. Thirty-eight patients have been seen, an average of three times at 3–4-monthly intervals. This has meant that the patients have been followed for about 12 months beyond the last tertiary hospital visit. The average driving distance from Brisbane per telehealth event was 612 km (range, 158–1824 km). The local service was based in hospitals or community health services, with multiple-site login to the RBWH (MND clinical nurse consultant, neurologist and palliative care physician) and TPCH (sleep physician and sleep nurse).
The major problems addressed at telehealth consultations were symptom-based, dominated by the respiratory and palliative concerns. Practical support was provided for general practitioners for managing symptoms (such as excess saliva, immobility and communication problems), the use and withdrawal of non-invasive ventilation, and end-of-life support.
The advantages of telehealth over traditional outpatient clinics include the continued support by personnel who are experienced in MND. Skype and other technologies would allow even greater access, but have issues of confidentiality and security. Telehealth may also reduce the sense of hopelessness that MND patients feel: there is something intangibly positive about finishing a consultation with “so should we make an appointment for 3 months time?”
Competing interests
No relevant disclosures.
References
- Vitacca M, Assoni G, Pizzocaro P, et al. A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance. J Telemed Telecare 2006; 12: 337-342. _Ref390240748
- Vitacca M, Comini L, Tentorio M, et al. A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J Telemed Telecare 2010; 16: 83-88. 2
- Nijeweme-d'Hollosy WO, Janssen EP, Huis in ‘t Veld RM, et al. Tele-treatment of patients with amyotrophic lateral sclerosis (ALS). J Telemed Telecare 2006; 12 Suppl 1: 31-34. _Ref390240750
- Kiernan MC, Talman P, Henderson RD, et al. Establishment of an Australian motor neurone disease registry. Med J Aust 2006; 184: 367-368. _Ref390241007
Motor Neuron Disease Mortality Trends in Australia From 1986 to 2023: A Population-Based Study
Carol M. Y. Lee, Rupendra N. Shrestha, Julian Gold, Mark Stevenson, Kelly L. Williams, Lyndal Henden, Sandrine K. K. Chan Moi Fat, Zoe Zussa, Amanda Wright, Martin Jude, Mark A. S. Laidlaw, Willem J. R. Fokkink, Dominic B. Rowe
Mild traumatic brain injury and concussion and persisting post‐concussion symptoms: new guidelines to support evidence‐based assessment and management in Australia and Aotearoa New Zealand
Karen M Barlow, Jennie L Ponsford, Alice Theodom, Gill Cowen, Gavin A Davis, Vicki Anderson, Franz E Babl, David Cole, Jennifer Cullen, Stuart R Dalziel, Melinda Fitzgerald, Howard Flavell, Caroline Yates, Rebecca Kimble, John H Olver, Rhonda Orr, Mark Ralfe, Michael Rose, Nick Rushworth, Julia Treleaven, Gary Browne, Nathan Delang, Sarah Harris, Gary Mitchell, Sean Tweedy
The prevalence of and variation in indicators of the quality and safety of long term aged care in Australia, 2019: a cross‐sectional population‐based study
Tesfahun C Eshetie, Gillian E Caughey, Catherine Lang, Olivia Ryan, Renuka Visvanathan, Craig Whitehead, Keith Evans, Janet K Sluggett, Jyoti Khadka, Carolyn Dawkins, Helena Williams, Miranda Starke, Sara Blunt, Anne Liddell, Megan Corlis, Anna Sheppeard, Penelope Lello, Marilyn Thien, Steven L Wesselingh, Maria C Inacio
Health and economic benefits of improving pre‐hospital identification of stroke in Australian women: a modelling study
Thomas Gadsden, Lei Si, Emily R Atkins, Cheryl Carcel, Xia Wang, Stephen Jan, Mark Woodward, Laura E Downey
Symptom burden, quality of life, and diagnostic journey of people with postural orthostatic tachycardia syndrome, Australia, 2021–24: a descriptive patient registry data study
Marie‐Claire Seeley, Gemma Wilson, Eric Ong, Amy Langdon, Jonathan Chieng, Danielle Bailey, Kristina Comacchio, Amanda Page, Dennis H Lau, Celine Gallagher
The intersection of rurality and dementia prevalence in Australia for Aboriginal and Torres Strait Islander and non‐Indigenous peoples
Antonia J Clarke, Marwan Ahmed, Judith M Katzenellenbogen, John Towney (Wiradjuri), Anna H Balabanski, Adrienne Withall (Dharawal Yuin), Kylie Radford, Amy Brodtmann